Real-world application of Short Term Psychodynamic Psychotherapy (STPP) as chronic migraine preventive therapy: Profiling responders and predictive factors
Alessandro Viganò(Sapienza University of Rome), Vittorio Di Piero(Sapienza University of Rome), Rita De Sanctis(Humanitas University), E Gilliéron(University of Florence), Marta Altieri(Sapienza University of Rome), Marta Puma, Jacopo Lanzone(Università Campus Bio-Medico), Angelo Bellinvia(University of Florence), Barbara Petolicchio(Policlinico Umberto I), Massimiliano Toscano(Fatebenefratelli Hospital), Romina Di Giambattista(Istituto Psicoanalitico per le Ricerche Sociali), Chiara Valota(Don Carlo Gnocchi Foundation), Paola Tiberio(Fondazione IRCCS Istituto Nazionale dei Tumori), Matteo Castaldo(University of Parma)
Cited by 1
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Challenges in Using Circulating miRNAs as Cancer Biomarkers
|BioMed Research International|2015|264
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|184
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178